Zenyth Operations Pty. Ltd.
10Patents
6Active
10Granted
38Portfolio score
Filing activity: Mar 10, 1998 → Jul 12, 2013 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7517524B2 | Immunointeractive molecules | Chemistry; Metallurgy | 2 | Active |
| US7186883B2 | In vitro propagation of embryonic stem cells | Chemistry; Metallurgy | 2 | Expired |
| US8221755B2 | Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1) | Chemistry; Metallurgy | 2 | Active |
| US7785590B2 | Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1) | Chemistry; Metallurgy | 2 | Active |
| US8506960B2 | Antibody molecule for human GM-CSF receptor alpha | Chemistry; Metallurgy | 1 | Active |
| US9085628B2 | Antibody molecule for human GM-CSF receptor alpha | Chemistry; Metallurgy | 0 | Active |
| US7220828B2 | Haemopoietin receptor and genetic sequence encoding same | Chemistry; Metallurgy | 0 | Expired |
| US8822644B2 | Method of treating cancer comprising a VEGF-B antagonist | Chemistry; Metallurgy | 0 | Active |
| US7192576B1 | Biologically active complex of NR6 and cardiotrophin-like-cytokine | Chemistry; Metallurgy | 0 | Expired |
| US7173001B2 | Method for regulating neuron development and maintenance | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.